Adenoma, Pleomorphic - 26 Studies Found

Completed : Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic Tumours
:
  • Cancer of the Ovary Treated as 2nd Line Therapy
  • Muellerian Mixed Tumou
    : 2005-09-12
    : Drug: Pegylated Liposomal Doxorubicin and Carboplatin
Completed : Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus
: Mixed Mullerian Tumors of the Uterus
: 2007-05-17
:
  • Drug: Gemcitabine Other Name:

Recruiting : Suitability of DCE-MRI for Detection of Vascular Changes After VBT
: Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
: 2013-11-11
: Radiation: Radiotherapy
Recruiting : Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -
: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas
: 2014-05-05
:
  • Drug: Pazopanib plus Gemcitabine

Completed : Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer
:
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma

: 2010-11-23
: Drug: Pazopanib Hydrochloride Given PO Other Names:
Active, not recruiting : Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer
:
  • Recurrent Uterine Sarcoma
  • Uterine Carcinosarcoma

: 2010-07-22
:
  • Drug: ixabepilone Given IV
Terminated : Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
:
  • Recurrent Uterine Sarcoma
  • Uterine Carcinosarcoma

: 2010-02-02
: Drug: temsirolimus Given IV Other Names:
Completed : Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma
: Uterine Carcinosarcoma
: 2008-05-28
:
  • Drug: paclitaxel Paclitaxel wi
Completed : Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
:
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma

: 2005-06-13
:
  • Drug: Gemcitabine Hydrochloride

Completed : Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Cancer
:
  • Recurrent Uterine Sarcoma
  • Uterine Carcinosarcoma

: 2004-01-09
:
  • Drug: imatinib mesylate Given

<<< Previous | Next >>>